Appeals Court Overturns $7.75M Vioxx Ruling

A Texas state appellate court has reversed a $7.75 million ruling against Merck & Co. Inc. over painkiller Vioxx, ruling that the plaintiffs failed to show that a pre-existing cardiovascular condition...

Already a subscriber? Click here to view full article